← Back to Clinical Trials
Recruiting NCT07440615

NCT07440615 Lower-Limb Muscle Mass and Cardiovascular and Muscular Performance in Males and Females

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07440615
Status Recruiting
Phase
Sponsor Uludag University
Condition Physical Performance
Study Type INTERVENTIONAL
Enrollment 235 participants
Start Date 2026-02-20
Primary Completion 2026-06-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Physical Performance Assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 235 participants in total. It began in 2026-02-20 with a primary completion date of 2026-06-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study will be to examine the relationship between leg muscle mass and muscle strength, aerobic capacity, anaerobic power, and jumping performance in young adults. In addition, these physical performance measures will be compared between male and female participants. Recreationally active young adults will be recruited to participate in the study. Body weight and leg muscle mass will be assessed using a body composition analyzer. Participants will perform isokinetic and isometric leg strength tests, an aerobic fitness test (VO₂max), an anaerobic power test (Wingate), and a countermovement jump (CMJ) test. This study aims to improve the understanding of the effects of leg muscle mass on physical performance and to identify possible differences between males and females. The findings are expected to contribute to exercise prescription, performance assessment, and future research in sports and health sciences.

Eligibility Criteria

Inclusion Criteria: * absent of lower body injuries that could impact testing; * were moderately physically active * did not ingest ergogenic aids or stimulant drugs for at least 6 months prior to the start of the study. Exclusion Criteria: \-

Contact & Investigator

Central Contact

Tuncay ALPARSLAN, Assoc.Prof.

✉ tuncayalparslan@hotmail.com

📞 Türkiye

Frequently Asked Questions

Who can join the NCT07440615 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Physical Performance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07440615 currently recruiting?

Yes, NCT07440615 is actively recruiting participants. Contact the research team at tuncayalparslan@hotmail.com for enrollment information.

Where is the NCT07440615 trial being conducted?

This trial is being conducted at Eskişehir, Turkey (Türkiye).

Who is sponsoring the NCT07440615 clinical trial?

NCT07440615 is sponsored by Uludag University. The trial plans to enroll 235 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology